(Q34555256)

3 August 2017

title

The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer (English)

1 reference

3 August 2017

Brian L Sprague

1

1 reference

3 August 2017

Amy Trentham-Dietz

series ordinal

2

1 reference

3 August 2017

Patrick L Remington

series ordinal

3

1 reference

3 August 2017

publication date

16 November 2010

1 reference

3 August 2017

published in

Cancer Causes & Control

1 reference

3 August 2017

volume

22

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

125-134

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-010-9682-7

3 August 2017

exact match

0 references

cites work

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Declines in breast cancer after the WHI: apparent impact of hormone therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

The decrease in breast-cancer incidence in 2003 in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Hormone therapy prescribing patterns in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Breast cancer and hormone-replacement therapy in the Million Women Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Postmenopausal estrogen and progestin use in relation to breast cancer risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Breast carcinoma in situ: risk factors and screening patterns

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Risk factors for in situ breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10552-010-9682-7

The impact of changes in hormone therapy on breast cancer incidence in the US population.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3034386

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

9 December 2018

1 reference

12 December 2020

Recent incidence trends for breast cancer in women and the relevance of early detection: an update

1 reference

12 December 2020

Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors

1 reference

12 December 2020

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

1 reference

12 December 2020

Recent trends in U.S. breast cancer incidence, survival, and mortality rates

1 reference

12 December 2020

Changing patterns in breast cancer incidence trends

1 reference

12 December 2020

Use of mammograms among women aged > or = 40 years--United States, 2000-2005

1 reference

12 December 2020

10.1007/S10552-010-9682-7

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference